Medicenna Therapeutics Investor Relations Material
Latest events
AGM 2024
Medicenna Therapeutics
Q4 2025
26 Jun, 2025
Corporate Presentation
28 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Medicenna Therapeutics Corp
Access all reports
Medicenna Therapeutics Corp. is a Canada-based clinical-stage biopharmaceutical company focused on the development of novel immunotherapies for cancer and other diseases. The company’s proprietary platforms are designed to create engineered cytokines, including interleukin-based therapies, aimed at enhancing immune system responses against tumors. The company is headquartered in Toronto, Canada, and its shares are listed on both the NASDAQ and the Toronto Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
MDNA
Country
🇨🇦 Canada